Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine is a mucolytic agent that breaks disulfide bonds in mucoproteins and a precursor to glutathione, essential for replenishing hepatic stores during acetaminophen toxicity.
## Primary Indications
* **Acetaminophen toxicity:** Antidote to bypass glutathione depletion.
* **Mucolytic therapy:** Adjunct in respiratory conditions with abnormal, viscid, or inspissated mucous secretions (e.g., cystic fibrosis, COPD).
* **Contrast-induced nephropathy (GIN) prophylaxis:** Efficacy is controversial and not universally recommended.
## Adult Dosing
* **Acetaminophen Toxicity (IV - Acetadote):**
* Loading: 150 mg/kg over 60 minutes.
* Second dose: 50 mg/kg over 4 hours.
* Third dose: 100 mg/kg over 16 hours.
* *Note: Follow local institutional protocol/Rumack-Matthew nomogram for timing.*
* **Acetaminophen Toxicity (Oral):**
* Loading: 140 mg/kg once.
* Maintenance: 70 mg/kg every 4 hours for 17 additional doses.
* **Mucolytic (Inhalation):** 1–10 mL of 20% solution or 2–20 mL of 10% solution via nebulizer every 2–6 hours.
## Pediatric Dosing
* **Acetaminophen Toxicity:** Same mg/kg dosing as adult IV/oral protocols. Use weight-based calculations strictly.
* **Mucolytic (Inhalation):** 3–5 mL of 20% solution or 6–10 mL of 10% solution via nebulizer 3–4 times daily.
## Dose Adjustments
* **Renal/Hepatic:** No specific dose adjustments for mucolytic use. For acetaminophen toxicity, infusion rates may be modified if fluid overload occurs, but the total dose remains critical.
## Contraindications
* Hypersensitivity to acetylcysteine.
* Oral administration is unsafe in patients with active GI bleeding or esophageal varices.
## Adverse Effects
* **Anaphylactoid reactions:** Common with IV use (flushing, urticaria, hypotension, wheezing). Stop infusion if reaction occurs; resume at slower rate or restart after antihistamines.
* **Respiratory:** Bronchospasm (most common with nebulized form; pretreat with bronchodilator).
* **GI:** Nausea, vomiting (common with oral protocol due to rotten-egg odor).
## Key Drug Interactions
* **Activated Charcoal:** May adsorb acetylcysteine. Administer charcoal at least 1 hour prior to oral acetylcysteine; if charcoal is already given, do not necessarily withhold the antidote, but consider the potential for delayed absorption.
* **Incompatibilities:** Do not mix inhaled acetylcysteine with tetracyclines, erythromycin, or amphotericin B.
## Monitoring
* **Acetaminophen Toxicity:** Serum acetaminophen levels, AST/ALT, bilirubin, prothrombin time/INR, creatinine, and electrolytes.
* **Mucolytic:** Monitor respiratory status, sputum consistency, and oxygen saturation.
## Clinical Pearls
* **Odor:** The formulation contains sulfur, resulting in an unpleasant odor; oral doses may be diluted in juice or soda to improve palatability.
* **IV Safety:** IV administration requires strict adherence to volume calculations to prevent hyponatremia and fluid overload, particularly in small children.
* **Status Update:** If an allergic reaction occurs to IV acetylcysteine, it is often manageable with antihistamines and rate reduction; it is rarely an IgE-mediated anaphylaxis.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical protocols vary by institution; always verify current prescribing information, institutional guidelines, and weight-based calculations via a reliable electronic database (e.g., Lexicomp, UpToDate) before prescribing or administering medication.